Express Pharma - Page 39 of 2240 - Express Pharma

Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings

Lupin receives USFDA approval for Phytonadione Injectable Emulsion

Why industry-academia collaboration will shape India’s next R&D chapter

We’re building for global markets, not just domestic scale

USFDA and EUDRA dashboards offer lessons for strengthening India’s regulatory transparency

From fintech to aesthetic injectables: Lessons in navigating regulatory formalisation

Karnataka holds 64th Vision Group on Biotechnology meeting to review biotech ecosystem

Glenmark launches Methylene Blue Injection USP in US

ILAMED expands international presence with centres in Kenya, Ethiopia and Thailand

Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer

Alembic receives USFDA final approval for Tretinoin Cream USP, 0.05%

Ipca Laboratories and Bhami’s Research Laboratory signs global licensing agreement for subcutaneous biologics platform

CDSCO’s cosmetic regulations: The rules exist. The enforcement does not